Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
SVB Leerink Initiates Coverage On MoonLake with Outperform Rating, Announces Price Target of $17
SVB Leerink analyst Thomas Smith initiates coverage on MoonLake (NASDAQ:MLTX) with a Outperform rating and announces Price Target of $17.
This Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday
Gainers
Magic Empire Global Limited (NASDAQ: MEGL) shares jumped 115.7% to close at $17.73 on volatility following the company's IPO earlier this month.
MoonLake Immunotherapeutics Signs Development And Manufacturing Agreement With Vetter Pharma International GmbH
MoonLake Immunotherapeutics AG ((MoonLake, NASDAQ:MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a Master Development
This Consumer Defensive Stock Is Trading Higher By Around 49%, Here Are 46 Stocks Moving In Friday’s Mid-Day Session
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares gained 93% to $10.32. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
HC Wainwright Starts Coverage On This ‘Best-In-Class Agent For Inflammatory Disorders
HC Wainwright initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $28, citing a potentially best-in-class…
HC Wainwright & Co. Initiates Coverage On MoonLake with Buy Rating, Announces Price Target of $28
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on MoonLake (NASDAQ:MLTX) with a Buy rating and announces Price Target of $28.